CW January 2002
Volume 11Issue Number 1 January 2002 ISSN 10593802 Cancer Vaccine for Non-Hodgkin?s LymphomaCustomized immunotherapy for aggressive non-Hodgkin?s lymphoma (NHL) can induce an anti-tumor response in most patients, just as a similar cancer vaccine has done in low-grade NHL patients.
Go to Previous Page Go to Next Page Source & Additional Reading J. Timmerman, American Society of Hematology Annual Meeting, Orlando, FL. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
